GDOL Los Angeles
GIST Day of Learning The Life Raft Group held a GIST Day of Learning (GDOL) in Los Angeles, California on February 18th, 2019. GDOLs are free, one-day programs that provide both education and support [...]
GIST Day of Learning The Life Raft Group held a GIST Day of Learning (GDOL) in Los Angeles, California on February 18th, 2019. GDOLs are free, one-day programs that provide both education and support [...]
Wondering what in the world Gastrointestinal Stromal Tumor (GIST) is? Longtime friend of the Life Raft Group and LRG Science Team member, Dr. David Josephy, presented the basics of cell biology in cancer, focusing [...]
Overall survival in GIST patients has improved dramatically over the years. In 2019, the median Overall Survival (OS) is over 12 years when all Life Raft Group registry patients are combined. About 80% of [...]
The liver, located under the right rib cage, is the body’s largest internal organ and acts as a factory, regulating digestion, blood content, nutrient production and storage. The liver processes all that funnels through [...]
Dr. Baker presenting at Michigan GDOL The Life Raft Group held its first GIST Day of Learning (GDOL) in Michigan on October 27th in Ann Arbor. GDOLs are free, one-day programs that [...]
Fall is finally here, and with it comes the onset of Flu Season. Flu is a difficult illness for everyone, but for cancer patients, it can be devastating. On average, 5 percent to 20 [...]
State of GIST: A Clinical Panel of Experts Presented by Jason Sicklick, MD, Moores Cancer Center, University of California, San Diego; and the GIST Experts Panel - Markku Martti Miettinen, MD, National [...]
Dina Wiley, SoCal Group Leader On August 11, 2018, a group of GISTers in Southern California gathered informally to share knowledge, resources, and personal stories about their journeys with this rare disease. [...]
So, I’ve been told that I have GIST! Life changes suddenly and profoundly when you receive a cancer diagnosis. It’s normal to experience a state of shock, but there is a practical need to [...]
Researchers have developed a test that can accurately identify over 20% of GIST patients that are unlikely to respond to currently approved treatments. In addition, it can identify which patients need a higher dose [...]